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Polymorphism of chlorpropamide on liquid-
assisted mechanical treatment: choice of liquid
and type of mechanical treatment matter†
Nadia Bouvart, ‡ab Roland-Marie Palix,‡ab Sergey G. Arkhipov, ac
Ivan A. Tumanov,ac Adam A. L. Michalchuk *ade and Elena V. Boldyreva *ac
Different types of mechanical treatment (tableting, grinding, milling, etc.) are important technological oper-
ations in the pharmaceutical industry. Solid materials are not merely comminuted during such treatment,
but can undergo polymorphic transitions and amorphisation. A liquid is often added to the solid sample on
purpose, e.g. in order to facilitate comminution. In many cases, liquid is present inadvertently, either as a
result of trace solvent following up-stream operations, or sorbed from the atmosphere. This work explores
the liquid-assisted mechanical treatment of two metastable forms of a model pharmaceutical compound
chlorpropamide (CPA), namely the β- and ε-forms. We investigate the stability of these polymorphs to me-
chanical treatment in the presence of a series of fluids that have affinity for different fragments of the CPA
molecule. In addition to variation in fluids, the effect of different mechanical treatment is explored,
employing model shear and restricted impact devices, alongside grinding in a mortar. CPA offers a clear
example of the drastically different results of shear and impact on mechanochemical polymorphism, on
the importance of the careful selection of solvent for liquid-assisted treatment, and on the possible role of
even trace quantities of solvent. Further, this work demonstrates the importance of the starting polymorph
in determining the outcome of a mechanochemical process. All of these factors can have notable conse-
quence on the outcome of technological operations that include mechanical treatment.
Introduction
Pharmaceutical compounds are often administered in the form
of a solid powder. The crystalline structure of these powder
particles plays an important role in determining the physico-
chemical properties of the pharmaceutical material, particu-
larly the dissolution dynamics.1–3 Different crystalline forms,
polymorphs, can display vastly different properties.4 The abil-
ity to control the crystalline form is therefore critical to ensure
the integrity of materials. The interrelation between crys-
tal structure and physico-chemical properties has led to
considerable work in controlling crystal form through selec-
tive crystallisation of polymorphs, or through the design of
multi-component materials.1–9 This has typically been done
through solution-based processes, although mechano-
chemical approaches, particularly milling, can be used.9–11
For pharmaceutical applications, one generally aims to pro-
duce a metastable phase of the crystalline material, which
displays higher solubility than the thermodynamically stable
form.
A variety of milling processes are employed in the indus-
trial processing of pharmaceutical materials.9–18 At present
this is generally aimed at reducing particle size with en-
hanced solubility properties. While dry milling techniques
are possible, the resulting powders are often highly metasta-
ble and the powder particles agglomerate quickly. Instead,
wet milling techniques have been shown to be more
promising.10,19–30 In these cases, milling is performed on a
suspension of particles in either aqueous or non-aqueous sol-
vents. The selection of solvent is often done so as to ensure
minimal dissolution of the system being milled, ease of dry-
ing, and to ensure any residual solvent is not toxic. The wet-
milled mixtures are investigated for possible contamination
by corroded material from the milling equipment, and for re-
sidual solvent. However, little concern is given towards the ef-
fects of the liquid on the integrity of the crystalline phase
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itself. This is particularly important, as the solid materials
are not merely comminuted during such treatment, but can
change or completely lose their crystal structure (polymor-
phic transitions and amorphisation, respectively), even if no
chemical changes of the molecular structure occurs. This
phenomenon can be termed as “structural instability”. Even
if a liquid is not added on purpose, it is often present in
trace quantities following previous operations, and can there-
fore inadvertently induce structural changes.
In the present work we explore the structural stability of a
model pharmaceutical material, chlorpropamide (CPA), a sul-
fonylurea compound used for treatment of type 2 diabetes
mellitus31 (Fig. 1).
CPA is well known to be extremely prone to
polymorphism.32–41 Although the α-form is thermodynami-
cally stable under ambient conditions, other forms can be
obtained, often concomitantly, as dominant phases or as
impurities.35–39 These metastable phases persist in mixtures
under ambient conditions, recrystallising only slowly to the
stable form, hastened by humid atmosphere. Obtaining any
metastable phase as a pure phase remains immensely chal-
lenging. Only a method for reproducibly obtaining ε-CPA is
known.39 The β- and ε-forms of CPA are the most interesting
for pharmaceutical applications, displaying the highest disso-
lution rates across the series of isolable CPA forms.42 A
method to obtain bulk quantities of β-CPA has not been doc-
umented prior to this work.
Transitions between polymorphs of the CPA on hydro-
static compression have been shown to depend strongly on
the presence of a pressure-transmitting fluid43 and on its
choice.44–46 CPA thus provides an intriguing system for fur-
ther analysis of the effects of different liquids on its polymor-
phism, including polymorphic transitions induced by me-
chanical treatment.
The molecular structure of CPA contains three chemically
unique segments, an aliphatic tail, a carbamide group, and a
halogenated aromatic (Fig. 1). Solvents have therefore been
explicitly selected to target interactions with specific compo-
nents of the CPA molecule. Toluene was selected to interact
with the aromatic fragment, and heptane was chosen to inter-
act with the hydrocarbon tail. Shorter hydrocarbons were not
selected due to their volatilities. The hydrogen bonding sol-
vent, ethanol, was selected to interact with the carbamide
group, with similar types of interactions expected by atmo-
spheric water. Chloroform was supposed to be able to inter-
act more or less equally with the alkyl tail and the chlori-
nated aromatic ring, but not with the sulphonamide
fragment or the urea core.
An earlier study on the mechanochemistry of the α- and
ε-polymorphs of CPA showed no transformation when dry
milled under ambient temperature in a vibratory ball mill.47
It has been documented for some other organic molecular
crystals that different types of treatment (such as shear or im-
pact) may have different or even opposing effects on a trans-
formation.48,49 It is therefore important to compare the out-
come of the transformations on different types of mechanical
treatment. In the present work we used custom-built model
devices48–52 to compare the effects of shear and restricted im-
pact, and compared them with the outcome of grinding with
a mortar and pestle.
The discovery of a new method to obtain pure β-CPA,
reported here, enabled us to explore the stability of both β-
and ε-CPA to mechanical manipulation for solid form pro-
cessing, depending on the choice of added liquid and the
type of mechanical treatment.
Experimental
Materials
All polymorphs were obtained starting from commercially
available chlorpropamide (Sigma Aldrich, 97%). Experiments
employed solvents heptane (Reachim, Russia), chloroform
(N°1 Chemical Reagents, Russia), ethanol (KPF, Russia) and
toluene (Reactiv, Russia). All materials were used without fur-
ther purification.
Growth of ε-chlorpropamide
Metastable ε-CPA was produced as described in an earlier
study.39 In this study, the metastable phase was obtained by
heating the commercially available α-form to 120 °C, holding
for 1 h, and cooling at approximately 0.5 °C min−1 to room
temperature.
Growth of β-chlorpropamide
The metastable β-CPA phase has proved challenging to reli-
ably reproduce. In the present work, a robust method for for-
mation of pure β-CPA was developed. Following the idea of
drop-wise crystallisation procedures published previously for
other compounds,53 a solution of CPA in chloroform was
placed drop-wise onto a pre-heated glass slide at 61 °C (hot
plate WiseStir MSH-20D was used). We note that the temper-
ature was very important to ensure that pure β-CPA was pro-
duced (ESI†). Each drop was carefully separated from
neighbouring drops, ensuring that crystallites did not re-
dissolve in newly added drops. Drops were left to evaporate
at this temperature, resulting in formation of β-CPA crystals.
Purity was confirmed by X-ray powder diffraction.
Manual grinding
Manual grinding was performed with an onyx mortar and
pestle at room temperature (ca. 25 °C) and relative humidity
(RH) of ca. 50–60%. For each experiment, a sample of ca. 30
mg was used. A series of experiments was also performed in
Fig. 1 Structural formula of a CPA molecule. The fragments differing
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a glove box under a dry N2 atmosphere, with RH <10%. For
LAG experiments by manual grinding, ca. 30 mg of material
was ground with a single drop of liquid (ca. 20 μL), giving a
liquid-to-solid ratio of η ≈ 0.67 μL mg−1.
Restricted impact
Mechanochemical experiments with restricted impact treat-
ment were performed in a custom model device, which has
been used and described in previous studies.50 Samples (ca.
30 mg) were subjected to a series of periodic mechanical im-
pacts. The kinetic energy of individual impacts was approxi-
mately 10 mJ per impact, with impact frequency of 3.33 Hz
(200 per minute). Each experiment was performed under the
same ambient conditions, with the same settings, for varying
lengths of time. Following mechanical treatment, the entire
powder sample was transferred immediately to the diffrac-
tometer for analysis by X-ray powder diffraction (XRPD). For
LAG experiments by restricted impact, ca. 30 mg of material
was ground with a single drop of liquid (ca. 20 μL), giving a
liquid-to-solid ratio of η ≈ 0.67 μL mg−1.
Shear
Shear treatment was performed in a second custom device,
described previously.48 Samples (ca. 30 mg) were subjected to
continuous mechanical shearing between two circular, rough-
ened glass plates, while under the pressure of several metal
weights. The estimated average pressure on the sample was 4
kPa. Mechanochemical experiments were performed under
the same ambient conditions, for varying lengths of time. Af-
ter each experiment the entire powder sample was trans-
ferred immediately to the diffractometer for analysis by X-ray
powder diffraction (XRPD). For LAG experiments by shear, ca.
30 mg of material was ground with a single drop of liquid
(ca. 20 μL), giving a liquid-to-solid ratio of η ≈ 0.67 μL mg−1.
Characterisation
All solid samples were characterised by X-ray powder diffrac-
tion (XRPD) using a STOE-MP diffractometer. The diffractom-
eter was equipped with a Cu anode (Kα1 1.5406 Å) and a bent
Ge(111) monochromator. XRPD patterns were collected in
transmission mode in steps of 0.015 deg, with collection time
2 s per step.
Results and discussion
Atmospheric stability of metastable chlorpropamide
As initial assessment of the effects of liquids on the metasta-
ble β- and ε-phases of CPA, samples of each material were
stored under low (ca. 10%) and high (ca. 90%) relative humid-
ity (RH) atmosphere. For both phases, no obvious transforma-
tion was detected when the sample was stored at 10% RH for
nine days. However, for samples stored under ca. 90% RH
polymorphic conversions were observed. In the case of ε-CPA,
the sample was found to have undergone notable conversion
to the thermodynamically stable α-phase within four days. In
contrast, the sample of β-CPA displayed similar conversion to
the α-phase only after seven days at ca. 90% RH (ESI†).
This strongly suggests that the transformation of the
metastable polymorphs to the stable form proceeds by
recrystallisation in atmospheric moisture. Interestingly, while
the molecular conformation in α-CPA more closely resembles
that of β-CPA35 (Fig. 2), the molecular packing in the crystal
structure of ε-CPA37 is more similar to that in α-CPA34
(Fig. 3). It is therefore logical to find that the latter transfor-
mation should occur more rapidly, in the presence of only
small quantities of solvent.
Previous work on the CPA polymorphs has shown that
both α- and β-polymorphs transform into the ε-form on slow
heating prior to melting, with the solid-state transformation
of the β-form into the ε-form being kinetically hindered. The
β-polymorph can therefore melt without conversion to the
ε-form if heated quickly.38,39 At ambient conditions the sta-
bility of the forms decreases as α > ε > β (ref. 39) under
ambient pressure. Recrystallisation of CPA in atmospheric
moisture therefore follows according to Ostwald's rule of
stages.54–56
Mechanical treatment of ε- and β-chlorpropamide under dry
or humid conditions
Initial manual grinding of the pure phases of the β- and
ε-forms of CPA under ambient conditions showed slow conver-
sion to the stable α-phase in each case (ESI†). This was to be
expected given the response of each material to humid sum-
mer atmosphere, and highlights the influence of humidity on
mechanochemical reactions as well as the accelerating effect
of grinding on solid state processes. In contrast, conducting
these same grinding processes under a dry atmosphere in a
glove box or in winter47 (<20% RH) resulted in no, or only
traces of transformation (Fig. 4 and ESI†). This is an example
of the seasonal irreproducibility of mechanochemical trans-
formations that are sensitive to the atmospheric humidity,
termed inadvertent liquid-assisted grinding.57
Liquid-assisted grinding (LAG) of ε- and β-chlorpropamide
A summary of the transformations of both metastable poly-
morphs of CPA is given in Fig. 5.
Fig. 2 Overlay of the asymmetric CPA molecule in the α-CPA (blue),
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Liquid-assisted grinding (LAG) of ε-chlorpropamide
As with manual ‘dry’ grinding under atmospheric humidity,
the grinding of ε-CPA in the presence of ethanol, toluene,
chloroform or heptane led to gradual conversion of ε →
α-CPA (ESI†). In all cases, only minimal grinding was re-
quired to observe initial signs of transformation. Industrially,
this is a promising result, where any seeds of ε-CPA that may
be present in the initial system (readily formed by heating),
can be easily removed by wet milling.
The same transformation was observed when ε-CPA was
subjected to impact treatment in most cases. When impact
was performed in the presence of chloroform or ethanol,
complete transformation to the α-phase was observed within
30 minutes. However, residual quantities of the starting
ε-phase remained after 30 minutes when impact was
performed in the presence of toluene (ESI†).
Interestingly, the addition of heptane to the impact reac-
tion occasionally induced formation of small quantities of an
impurity phase. In such small quantities it is difficult to as-
sign this phase unambiguously (ESI†). However, it appears
that the impurity phase can be either the α- or closely related
δ-phase, depending on the experiment. Despite the minor im-
purity forming, the majority of powder remains as the origi-
nal ε-form, Fig. 6. The possibility to control selective forma-
tion of the α- or δ-forms under restricted impact treatment
with heptane will be the subject of further investigation, but
may be associated with residual atmospheric moisture in
some cases. We note that in both the ε and α-phases, the al-
kyl tail of the CPA molecule is linear, but bent in the δ-form.
The formation of δ-CPA in the presence of heptane corre-
sponds to the known crystallisation of the δ-form from hep-
tane–ethyl acetate solution,37 believed to be associated with
interaction of the solvent alkyl chains with the CPA tail on
recrystallisation.45 This suggests that wet mechanochemical
processing proceeds via solution-phase intermediates.
Pure shear treatment under atmospheric conditions led to
conversion of the ε-form towards the thermodynamic α-phase.
This same transformation was also observed in the presence
of all tested solvents, including heptane (ESI†), and is consis-
tent with the results of manual grinding. However, this result
differs from that obtained by restricted impact, where only
traces of conversion were observed when conducted in the
presence of heptane. This clearly demonstrates the notable dif-
ferences in the effects of impact and shear mechanical treat-
ment on the transformation of solids.48
Liquid-assisted grinding (LAG) of β-chlorpropamide
The effect of mechanical treatment on β-CPA was different
from that observed for the ε-phase. Manual grinding of the
β-form in the presence of toluene, ethanol or chloroform led
to conversion of β-CPA to the α-polymorph in less than 30
minutes. Again, this suggests that any polymorph impurities
of CPA can be readily removed by wet milling in these sol-
vents, provided the α-phase is targeted. Instead, manual
grinding in the presence of heptane led to a mixture of CPA
polymorphs. Clear evidence of the α- and δ-forms is evident
within only 15 minutes of grinding (ESI†). Rietveld refine-
ment suggesting a nearly 70 : 30 mixture of the two phases is
formed at this stage, with α-CPA being dominant. Only traces
of β-CPA remain in this mixture. Again, this is consistent
Fig. 3 Molecular packing in the crystal structures of the (A) α-, (B) ε-
and (C) β-forms of CPA. Structures are viewed along the crystallo-
graphic c-axis. Structural data from ref. 34, 35 and 37.
Fig. 4 Schematic influence of humidity on CPA phase conversion.
Both forms convert to α-CPA when manually ground under a humid
atmosphere. No conversion is found under dry atmosphere.
Fig. 5 Schematic summary of the mechanically-induced transforma-
tions of ε- and β-CPA. (A) Transformation observed under all types of
mechanical treatment in the presence of moisture, ethanol, chloro-
form or toluene. Specific reactivity under restricted impact (I), manual




























































































CrystEngComm, 2018, 20, 1797–1803 | 1801This journal is © The Royal Society of Chemistry 2018
with the ability of the δ-form to be produced from heptane–
ethyl acetate solutions.37
The impact treatment of β-CPA in the presence of ethanol,
toluene and chloroform led to rapid conversion to the α-form
(ESI†). However, in contrast to impact treatment of ε-CPA
with heptane, treatment of β-CPA under these conditions led
to near complete conversion to the δ-phase in 20 minutes of
treatment, Fig. 6. The purity of the δ-phase continued to grow
with increased treatment time (ESI†).
Shear treatment of β-CPA under atmospheric conditions,
or in the presence of ethanol, toluene and chloroform led to
conversion towards the α-form. Instead, shear treatment of
β-CPA in the presence of heptane led to unmistakable conver-
sion of the material into the γ-form, Fig. 6. This is in striking
contrast to the effects of impact treatment on the β-form in
the presence of the same solvent, and is another example (in
addition to those reported before48,49) of drastically different
effects of shear and impact on mechanically induced
processes.
Both metastable polymorphs are therefore found to react
differently under the same mechanical treatment. This offers
a new dimensionality to the design and control of mechano-
chemical reactions, where not only must one control the sol-
vent used for LAG, but also the starting polymorphic form.
Further, as found in the case of β-CPA, it is not sufficient to
control only the solvent and the polymorphic form. One must
also give thought to the type of mechanical treatment to be
used, when designing a mechanochemical process.
Conclusions
Mechanochemical methods are crucial for the processing of
powder materials. In industry, these processes are generally
used for the reduction of particle size, with wet milling being
most commonly used. The presence of solvent can have dras-
tic influence on the outcome of the mechanical treatment,
and can greatly affect the nature of the resulting material.
This has been identified for a number of systems, and is of
growing importance.58–65 With CPA, mechanically influenced
transformations are found to be solution-mediated, and are
inhibited for both the β- and ε-forms when conducted in dry
atmosphere. In all cases, the use of water (atmospheric), tolu-
ene, chloroform or ethanol leads to conversion of CPA to-
wards the thermodynamically stable α-form. However,
conducting mechanical treatment in the presence of heptane,
expected to interact with the alkyl tail of CPA molecules, has
considerably different effects.
Restricted impact of ε-CPA in the presence of heptane led
to nearly no conversion of the material. Instead, shear treat-
ment in this solvent was accompanied by complete conver-
sion to the α-form. The effects of heptane on the mechano-
chemistry of β-CPA were notably different. Restricted impact
of β-CPA in the presence of heptane led to near complete
conversion to the δ-form. However, shear treatment of β-CPA
with heptane resulted in conversion to the γ-phase. Interest-
ingly, on hydrostatic compression in a similar alkane fluid
(pentane–isopentane mixture), β-CPA transforms into pure
γ-CPA if no other phases are present in the system. However,
if seeds of δ-CPA are present, these seeds grow in size (al-
though no new δ-CPA crystals nucleate), concomitantly with
the fast nucleation and growth of new γ-CPA crystals.45 This
complex interplay of kinetics and thermodynamics is likely
responsible for the drastically different results observed for
the mechanochemistry of β-CPA.
Dissolution and re-crystallisation play a critical role in the
mechanically-induced polymorphism of CPA. The same is
true for many other organic systems. Many factors can affect
the outcome of this recrystallisation, and thus the resulting
product of the reaction. The present study highlights the im-
portance of the starting polymorph, the choice of fluid, and
the type of mechanical treatment (shear, impact, or hydro-
static compression) in designing a mechanochemical experi-
ment. The design of mechanochemical processes clearly re-
quires careful selection of all of these factors.
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Fig. 6 (A) XRPD pattern of ε-CPA after impact treatment with heptane,
(B) XRPD pattern of β-CPA converted into γ-form after shear treatment
with heptane, and simulated XRPD patterns for (1) β-CPA, (2) ε-CPA, (3)
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